Cardiovascular Effects of Medications for the Treatment of Attention-Deficit Hyperactivity Disorder: What is Known and How Should it Influence Prescribing in Children?

By Elia Josephine   Vetter Victoria L.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 165-175

Adis International

Access to resources Recommend Favorite

Is Attention-Deficit Hyperactivity Disorder (ADHD) Diagnosed in Adults?: An Examination of US Office-Based Physician Visits, 1995−2000

By Robison Linda M.   Skaer Tracy L.   Sclar David A.  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 6, 2004-01 ,pp. : 337-341

Adis International

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder in Girls: Epidemiology and Management

By Staller Jud   Faraone Stephen V.  

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 107-123

Adis International

Access to resources Recommend Favorite

Compliance with Stimulants for Attention-Deficit/ Hyperactivity Disorder: Issues and Approaches for Improvement

By Swanson J.  

CNS Drugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 117-131

Adis International

Access to resources Recommend Favorite

Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder

By Weisler Richard H  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 745-758

Informa Healthcare

Access to resources Recommend Favorite